| 1 day | -4.89% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Lévesque
CEO | Chief Executive Officer | 62 | 06/04/2020 |
Philippe Dubuc
DFI | Director of Finance/CFO | 59 | 24/02/2016 |
| Chief Tech/Sci/R&D Officer | 63 | 01/01/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Dawn Svoronos
CHM | Chairman | 72 | 08/04/2013 |
Andrew Molson
BRD | Director/Board Member | 58 | 16/10/2020 |
| Director/Board Member | 70 | 16/05/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/10/25 | Marche | Executive/Senior Manager | 795 | 0.0017% | ||
| 29/09/25 | Marche | Executive/Senior Manager | 2,768 | 0.0060% | ||
| 29/09/25 | Marche | Executive/Senior Manager | 795 | 0.0017% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.89% | -2.40% | - | - | 148M | ||
| -0.82% | +1.40% | +40.13% | +143.17% | 1,286B | ||
| -1.12% | +0.16% | +41.57% | +88.24% | 688B | ||
| -0.16% | +0.43% | +25.88% | +113.01% | 521B | ||
| +1.14% | +4.87% | +43.06% | +71.97% | 386B | ||
| -2.23% | -2.89% | +55.57% | +41.64% | 364B | ||
| +1.27% | +2.01% | +30.01% | +62.35% | 302B | ||
| +0.37% | +0.75% | +3.71% | +39.09% | 287B | ||
| -0.72% | -0.63% | +35.30% | +71.87% | 252B | ||
| -0.30% | -1.03% | +35.05% | +124.88% | 208B | ||
| Average | -0.61% | +2.08% | +34.47% | +84.03% | 477B | |
| Weighted average by Cap. | -0.33% | +3.26% | +36.53% | +98.00% |
Employees
103
Sector
Pharmaceuticals
















